Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neus Villamor

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Current Protocols in Cytometry|September 5, 2008
ZAP-70 staining in chronic lymphocytic leukemiaNeus Villamor
Haematologica|January 16, 2014
Chronic lymphocytic leukemia in young individuals revisitedJulio Delgado, Neus Villamor
Haematologica|July 15, 2003
ZAP-70 expression in CLL: a new parameter for an old diseaseFrancesc Bosch, Neus Villamor
Current Pharmaceutical Design|March 26, 2004
Cytotoxic effects of B lymphocytes mediated by reactive oxygen speciesNeus Villamor, Emili Montserrat, Dolors Colomer
Seminars in Oncology|August 27, 2003
Mechanism of action and resistance to monoclonal antibody therapyNeus Villamor, Emili Montserrat, Dolors Colomer
Blood|March 2, 2002
Different clinical value of minimal residual disease after autologous and allogenic stem cell transplantation for chronic lymphocytic leukemiaJordi Esteve, Neus Villamor, Dolors Colomer, et al.
Best Practice & Research. Clinical Haematology|October 16, 2016
Genetic evolution in chronic lymphocytic leukaemiaJulio Delgado, Neus Villamor, Armando López-Guillermo, et al.
Seminars in Hematology|November 20, 2013
Next-generation sequencing in chronic lymphocytic leukemiaNeus Villamor, Armando López-Guillermo, Carlos López-Otín, et al.
Haematologica|September 2, 2014
Survival analysis in hematologic malignancies: recommendations for cliniciansJulio Delgado, Arturo Pereira, Neus Villamor, et al.
Blood|January 18, 2007
The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of BakPatricia Pérez-Galán, Gaël Roué, Neus Villamor, et al.
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Current Protocols in Cytometry|September 5, 2008
ZAP-70 staining in chronic lymphocytic leukemiaNeus Villamor
Haematologica|January 16, 2014
Chronic lymphocytic leukemia in young individuals revisitedJulio Delgado, Neus Villamor
Haematologica|July 15, 2003
ZAP-70 expression in CLL: a new parameter for an old diseaseFrancesc Bosch, Neus Villamor
Current Pharmaceutical Design|March 26, 2004
Cytotoxic effects of B lymphocytes mediated by reactive oxygen speciesNeus Villamor, Emili Montserrat, Dolors Colomer
Seminars in Oncology|August 27, 2003
Mechanism of action and resistance to monoclonal antibody therapyNeus Villamor, Emili Montserrat, Dolors Colomer
Blood|March 2, 2002
Different clinical value of minimal residual disease after autologous and allogenic stem cell transplantation for chronic lymphocytic leukemiaJordi Esteve, Neus Villamor, Dolors Colomer, et al.
Best Practice & Research. Clinical Haematology|October 16, 2016
Genetic evolution in chronic lymphocytic leukaemiaJulio Delgado, Neus Villamor, Armando López-Guillermo, et al.
Seminars in Hematology|November 20, 2013
Next-generation sequencing in chronic lymphocytic leukemiaNeus Villamor, Armando López-Guillermo, Carlos López-Otín, et al.
Haematologica|September 2, 2014
Survival analysis in hematologic malignancies: recommendations for cliniciansJulio Delgado, Arturo Pereira, Neus Villamor, et al.
Blood|January 18, 2007
The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of BakPatricia Pérez-Galán, Gaël Roué, Neus Villamor, et al.
Pageof 16